Avience Biomedicals Limited (NSE: AVIENCE), ISIN INE0V9I01017 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
AVIENCE last traded at ₹268.55 (+4.94%), with a 52-week range of ₹222.00 to ₹414.95 (as of 25 Aug 2026).
Shareholding as of Mar 2026: promoters 64.59%, FIIs 3.06%, DIIs 9.08%, mutual funds 0.25%.
EquiSense Score (ECS): 64/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.